Cargando…

Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial

BACKGROUND: Despite shortening vasopressor use in shock, hydrocortisone administration remains controversial, with potential harm to the immune system. Few studies have assessed the impact of hydrocortisone on the transcriptional response in shock, and we are lacking data on burn shock. Our objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Plassais, Jonathan, Venet, Fabienne, Cazalis, Marie-Angélique, Le Quang, Diane, Pachot, Alexandre, Monneret, Guillaume, Tissot, Sylvie, Textoris, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473974/
https://www.ncbi.nlm.nih.gov/pubmed/28623938
http://dx.doi.org/10.1186/s13054-017-1743-9
_version_ 1783244385457012736
author Plassais, Jonathan
Venet, Fabienne
Cazalis, Marie-Angélique
Le Quang, Diane
Pachot, Alexandre
Monneret, Guillaume
Tissot, Sylvie
Textoris, Julien
author_facet Plassais, Jonathan
Venet, Fabienne
Cazalis, Marie-Angélique
Le Quang, Diane
Pachot, Alexandre
Monneret, Guillaume
Tissot, Sylvie
Textoris, Julien
author_sort Plassais, Jonathan
collection PubMed
description BACKGROUND: Despite shortening vasopressor use in shock, hydrocortisone administration remains controversial, with potential harm to the immune system. Few studies have assessed the impact of hydrocortisone on the transcriptional response in shock, and we are lacking data on burn shock. Our objective was to assess the hydrocortisone-induced transcriptional modulation in severe burn shock, particularly modulation of the immune response. METHODS: We collected whole blood samples during a randomized controlled trial assessing the efficacy of hydrocortisone administration in burn shock. Using whole genome microarrays, we first compared burn patients (n = 32) from the placebo group to healthy volunteers to describe the transcriptional modulation induced by burn shock over the first week. Then we compared burn patients randomized for either hydrocortisone administration or placebo, to assess hydrocortisone-induced modulation. RESULTS: Study groups were similar in terms of severity and major outcomes, but shock duration was significantly reduced in the hydrocortisone group. Many genes (n = 1687) were differentially expressed between burn patients and healthy volunteers, with 85% of them exhibiting a profound and persistent modulation over seven days. Interestingly, we showed that hydrocortisone enhanced the shock-associated repression of adaptive, but also innate immunity. CONCLUSIONS: We found that the initial host response to burn shock encompasses wide and persistent modulation of gene expression, with profound modulation of pathways associated with metabolism and immunity. Importantly, hydrocortisone administration may worsen the immunosuppression associated with severe injury. These data should be taken into account in the risk ratio of hydrocortisone administration in patients with inflammatory shock. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00149123. Registered on 6 September 2005. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1743-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5473974
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54739742017-06-21 Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial Plassais, Jonathan Venet, Fabienne Cazalis, Marie-Angélique Le Quang, Diane Pachot, Alexandre Monneret, Guillaume Tissot, Sylvie Textoris, Julien Crit Care Research BACKGROUND: Despite shortening vasopressor use in shock, hydrocortisone administration remains controversial, with potential harm to the immune system. Few studies have assessed the impact of hydrocortisone on the transcriptional response in shock, and we are lacking data on burn shock. Our objective was to assess the hydrocortisone-induced transcriptional modulation in severe burn shock, particularly modulation of the immune response. METHODS: We collected whole blood samples during a randomized controlled trial assessing the efficacy of hydrocortisone administration in burn shock. Using whole genome microarrays, we first compared burn patients (n = 32) from the placebo group to healthy volunteers to describe the transcriptional modulation induced by burn shock over the first week. Then we compared burn patients randomized for either hydrocortisone administration or placebo, to assess hydrocortisone-induced modulation. RESULTS: Study groups were similar in terms of severity and major outcomes, but shock duration was significantly reduced in the hydrocortisone group. Many genes (n = 1687) were differentially expressed between burn patients and healthy volunteers, with 85% of them exhibiting a profound and persistent modulation over seven days. Interestingly, we showed that hydrocortisone enhanced the shock-associated repression of adaptive, but also innate immunity. CONCLUSIONS: We found that the initial host response to burn shock encompasses wide and persistent modulation of gene expression, with profound modulation of pathways associated with metabolism and immunity. Importantly, hydrocortisone administration may worsen the immunosuppression associated with severe injury. These data should be taken into account in the risk ratio of hydrocortisone administration in patients with inflammatory shock. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00149123. Registered on 6 September 2005. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1743-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-16 /pmc/articles/PMC5473974/ /pubmed/28623938 http://dx.doi.org/10.1186/s13054-017-1743-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Plassais, Jonathan
Venet, Fabienne
Cazalis, Marie-Angélique
Le Quang, Diane
Pachot, Alexandre
Monneret, Guillaume
Tissot, Sylvie
Textoris, Julien
Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
title Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
title_full Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
title_fullStr Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
title_full_unstemmed Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
title_short Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
title_sort transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473974/
https://www.ncbi.nlm.nih.gov/pubmed/28623938
http://dx.doi.org/10.1186/s13054-017-1743-9
work_keys_str_mv AT plassaisjonathan transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial
AT venetfabienne transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial
AT cazalismarieangelique transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial
AT lequangdiane transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial
AT pachotalexandre transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial
AT monneretguillaume transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial
AT tissotsylvie transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial
AT textorisjulien transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial